| GGORX | RPTIX | GGORX / RPTIX | |
| Total Expense Ratio | 1.41 | 0.63 | 224% |
| Annual Report Gross Expense Ratio | 1.62 | 0.63 | 257% |
| Fund Existence | 18 years | 10 years | - |
| Gain YTD | 9.451 | 3.369 | 281% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 500000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 999M | 25.9B | 4% |
| Annual Yield % from dividends | 0.00 | 0.05 | - |
| Returns for 1 year | -11.21 | -8.70 | 129% |
| Returns for 3 years | 12.42 | 10.44 | 119% |
| Returns for 5 years | -35.93 | -6.04 | 595% |
| Returns for 10 years | -52.24 | 31.48 | -166% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AMDG | 45.02 | 6.83 | +17.88% |
| Leverage Shares 2X Long AMD Daily ETF | |||
| HQL | 16.98 | 0.22 | +1.31% |
| abrdn Life Sciences Investors | |||
| BTA | 9.56 | 0.01 | +0.10% |
| Blackrock Long-Term Municipal Advantage Trust | |||
| JMST | 50.92 | 0.01 | +0.02% |
| JPMorgan Ultra-Short Municipal Inc ETF | |||
| HELX | 34.90 | N/A | N/A |
| Franklin Genomic Advancements ETF | |||